Quanterix Corporation Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
Quanterix Corporation (QTRX) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $58.45 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-03-02
- Quanterix Corporation valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $58.45M, a 581.10% increase from fiscal 2024.
- Quanterix Corporation valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $8.58M, a 27.88% increase from fiscal 2023.
- Quanterix Corporation valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $6.71M, a 67.61% decline from fiscal 2022.
- Quanterix Corporation valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $20.72M, a 6.18% increase from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | $58.45M 10-K · filed 2026-03-02 | |
| 2024-12-31 | $8.58M 10-K · filed 2026-03-02 | |
| 2023-12-31 | $6.71M 10-K · filed 2025-03-17 | $7.90M 10-K · filed 2024-02-29 |
| 2022-12-31 | $20.72M 10-K/A · filed 2024-12-26 | $20.12M 10-K · filed 2023-03-06 |
| 2021-12-31 | $19.51M 10-K · filed 2023-03-06 | |
| 2020-12-31 | $9.47M 10-K · filed 2022-03-01 | |
| 2019-12-31 | $10.10M 10-K · filed 2021-03-05 | $10.10M 10-K · filed 2020-03-13 |
| 2018-12-31 | $9.40M 10-K · filed 2019-03-18 | |
| 2017-12-31 | -$3.90M 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |